CDKN1C and acute myeloid leukemia: The status of CDKN1C expression could also be tested in other cancers as 5-azacytidine plus entinostat regimen has been successfully tested on patients with AML arising after chemotherapy or radiation therapy, breast cancer and colorectal cancer5,7.